Previously, another group of scientists found increased expression of the N-MYC oncogene in hematopoietic cells of children with AML who were carriers of AML1-ETO or CBFβ-MYH11 mutations [19]. The gene discussed is MYH11; the disease is acute myeloid leukemia.